UnitedHealth: This Rally Is Lacking Substance; Sell Now (Archive)

This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.

Elevator Pitch

• Rising medical cost ratios are expected to worsen in 2026, and recent regulations limit pricing gains, pressuring gross margins.
• Delayed data on superinvestors' buys is not a sufficient reason for becoming bullish on UNH, especially as there is no major bullish improvement on the fundamentals.
• Broadening scope of DoJ probes into the pharmacy benefit management business adds another risk wildcard.
• Recent bullish activity by superinvestors is seen as unreliable, with delayed 13F data and no meaningful upgrades in Wall Street EPS estimates for UNH.
• Valuation analysis shows UNH is overvalued relative to peers, as the recent rally is purely driven by hype-driven multiple expansion. The relative technicals are at a resistance level too.

Read the full article here.